SERA News and Press, Sera Prognostics Inc. From 10/27/22

Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2022 Financial Results on November 9 PR Newswire SALT LAKE CITY , Oct. 27, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), ...

SONRAVA HEALTH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH CEREBRAE AND SERA PROGNOSTICS PR Newswire The value created by applying Sera's PreTRM® test and treat strategy ...

BANNER HEALTH, SERA PROGNOSTICS TEAM UP TO PROVIDE PreTRM® TEST TO COVERED PREGNANT MEMBERS PR Newswire First and only broadly clinically validated test to provide accurate and actionable information to help reduce the morbidity, mortality, and costs associate...

Image source: The Motley Fool. Sera Prognostics, Inc. (NASDAQ: SERA) Q2 2022 Earnings Call Aug 10, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Sera Prognostics, Inc. (SERA) Q2 2022 Earnings Call Transcript

Sera Prognostics, Inc. (SERA) Q2 2022 Earnings Conference Call August 10, 2022 05:00 PM ET Company Participants Peter DeNardo - CapComm Partners Greg Critchfield - Chairman, President & Chief Executive Officer Jay Moyes - Chief Financial Officer Confere...

Sera Prognostics press release ( NASDAQ: SERA ): Q2 GAAP EPS of -$0.37 beats by $0.03 . Revenue of $0.07M (+250.0% Y/Y) misses by $0.02M . For further details see: Sera Prognostics GAAP EPS of -$0.37 beats by $0.03, revenue of $0.07M misses by $0.02M

SERA PROGNOSTICS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS PR Newswire SALT LAKE CITY , Aug. 10, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing inn...

SERA sells PreTRM®, a CLIA-lab based assay to determine the risk of a woman having a pre-term birth – a birth prior to 37 weeks of gestation. After IPO'ing in July 2021 at $16, the Company has since lost over 80% of its value and trades at 50% of its cash and marketable se...

Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2022 Financial Results on August 10 PR Newswire SALT LAKE CITY , July 28, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company ® (Nasdaq: SERA), foc...

Gainers: Endo International plc (ENDP) +95%. Agile Therapeutics (AGRX) +66%. Kezar Life Sciences (KZR) +53%. Decibel Therapeutics (DBTX) +25%. Ceragon Networks (CRNT) +23%. InflaRx (IFRX) +20%. Sutro Biopharma (STRO) +19%. Tyra Biosciences (TYRA) +17%. Oasis Petroleum (OAS) +16%. Biotricity (...